|
KLHL26 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.216180E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.954260E-02 |
| Normal-vs-Stage2 |
1.373890E-02 |
| Normal-vs-Stage3 |
7.221800E-02 |
| Normal-vs-Stage4 |
2.156600E-01 |
| Stage1-vs-Stage2 |
2.165000E-01 |
| Stage1-vs-Stage3 |
8.274800E-01 |
| Stage1-vs-Stage4 |
3.615600E-01 |
| Stage2-vs-Stage3 |
1.981630E-01 |
| Stage2-vs-Stage4 |
9.889700E-02 |
| Stage3-vs-Stage4 |
5.392000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.884300E-03 |
| Normal-vs-AfricanAmerican |
1.112840E-01 |
| Normal-vs-Asian |
4.099000E-01 |
| Caucasian-vs-AfricanAmerican |
9.953400E-01 |
| Caucasian-vs-Asian |
2.385000E-01 |
| AfricanAmerican-vs-Asian |
4.079800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.961700E-03 |
| Normal-vs-Female |
5.150000E-02 |
| Male-vs-Female |
2.206400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.127720E-02 |
| Normal-vs-Age(41-60Yrs) |
2.208400E-02 |
| Normal-vs-Age(61-80Yrs) |
8.143900E-02 |
| Normal-vs-Age(81-100Yrs) |
6.667600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.839800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.631800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.131400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.895000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.856400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.544800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.642170E-02 |
| Classical-VS-Follicular |
9.633900E-02 |
| Classical-VS-Other |
8.696800E-01 |
| Classical-VS-Normal |
1.999350E-03 |
| Tall-VS-Follicular |
4.221200E-01 |
| Tall-VS-Other |
3.578600E-01 |
| Tall-VS-Normal |
7.112600E-01 |
| Follicular-VS-Other |
7.117200E-01 |
| Follicular-VS-Normal |
2.120000E-01 |
| Other-VS-Normal |
2.846600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.613920E-02 |
| Normal-vs-N1 |
3.788400E-01 |
| N0-vs-N1 |
2.920600E-01 |
|
|
